Trial Profile
A Randomized, Placebo Controlled Trial of Botulinum Toxin for Paratonic Rigidity in People With Advanced Cognitive Impairment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Alzheimer's disease; Cognition disorders; Dementia
- Focus Therapeutic Use
- 15 Aug 2014 New trial record